CAMBRIDGE, Mass.--(EON: Enhanced Online News)--Foundation Medicine, Inc. (NASDAQ: FMI) today announced that financial results for the company’s third quarter ended September 30, 2013 will be released on Wednesday, November 6, 2013. The management team will host a conference call discussing the company’s financial results and recent developments on Wednesday, November 6, 2013 at 4:30 p.m. (ET). The call can be accessed by dialing 1-877-941-2069 (domestic) or 1-480-629-9713 (international) five minutes prior to the start of the call and providing the passcode 4647488.
The live, listen-only webcast of the conference call can be accessed by visiting the investors section of the Foundation Medicine website at investors.foundationmedicine.com. A replay of the webcast will be available shortly after the conclusion of the call and archived on the company’s website for two weeks following the call.
About Foundation Medicine
Foundation Medicine® (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's initial clinical assay, FoundationOne™, is a fully informative genomic profile to identify a patient's individual molecular alterations and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit www.FoundationMedicine.com or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® is a registered trademark, and FoundationOne™ is a trademark, of Foundation Medicine, Inc.